IBS007125

Overview

IBS007125 is a c-Maf inhibitor. IBS007125 does not alter the protein level or post-translational modification of c-Maf . IBS007125 inhibits some target genes of c-Maf (such as ITGB7 and CCR1 ). IBS007125 exerts anticancer effects on multiple myeloma expressing c-Maf . IBS007125 can be used for the research of multiple myeloma.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Multiple Myeloma | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > CCR

Product Information

• Catalog No.: HY-185661
• CAS No.: 2941099-67-6
• Molecular Formula: C14H18N4O
• Molecular Weight: 258.32
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source